Oxtriphylline - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for oxtriphylline and what is the scope of patent protection?
Oxtriphylline
is the generic ingredient in four branded drugs marketed by Parke Davis, Morton Grove, Watson Labs, and Warner Chilcott Llc, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.There are three drug master file entries for oxtriphylline.
Summary for oxtriphylline
| US Patents: | 0 |
| Tradenames: | 4 |
| Applicants: | 4 |
| NDAs: | 7 |
| Drug Master File Entries: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 37 |
| Patent Applications: | 5,327 |
| DailyMed Link: | oxtriphylline at DailyMed |
US Patents and Regulatory Information for oxtriphylline
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parke Davis | CHOLEDYL | oxtriphylline | TABLET, DELAYED RELEASE;ORAL | 009268-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Morton Grove | OXTRIPHYLLINE PEDIATRIC | oxtriphylline | SYRUP;ORAL | 088242-001 | Dec 5, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Warner Chilcott Llc | CHOLEDYL SA | oxtriphylline | TABLET, EXTENDED RELEASE;ORAL | 086742-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Parke Davis | CHOLEDYL | oxtriphylline | TABLET, DELAYED RELEASE;ORAL | 009268-007 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
